PDCD1 and neoplasm: Lung adenocarcinoma with co-mutations of Kirsten rat sarcoma viral oncogene homologue (KRAS) and loss of function of STK11/LKB1 also reduce tumor T cell infiltration and are predictive of relapse and poor outcome in patients who have undergone anti-PD-1 treatment [42,43].